EPIRUBICIN HYDROCHLORIDE
EPIRUBICIN HYDROCHLORIDE
Approval overview EPIRUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 091599 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient EPIRUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 200MG/100ML (2MG/ML) Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-12-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPIRUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 091599 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPIRUBICIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 200MG/100ML (2MG/ML) Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-12-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.